UniProt ID | PHF20_HUMAN | |
---|---|---|
UniProt AC | Q9BVI0 | |
Protein Name | PHD finger protein 20 | |
Gene Name | PHF20 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1012 | |
Subcellular Localization | Nucleus . | |
Protein Description | Methyllysine-binding protein, component of the MOF histone acetyltransferase protein complex. Not required for maintaining the global histone H4 'Lys-16' acetylation (H4K16ac) levels or locus specific histone acetylation, but instead works downstream in transcriptional regulation of MOF target genes (By similarity). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. Contributes to methyllysine-dependent p53/TP53 stabilization and up-regulation after DNA damage.. | |
Protein Sequence | MTKHPPNRRGISFEVGAQLEARDRLKNWYPAHIEDIDYEEGKVLIHFKRWNHRYDEWFCWDSPYLRPLEKIQLRKEGLHEEDGSSEFQINEQVLACWSDCRFYPAKVTAVNKDGTYTVKFYDGVVQTVKHIHVKAFSKDQNIVGNARPKETDHKSLSSSPDKREKFKEQRKATVNVKKDKEDKPLKTEKRPKQPDKEGKLICSEKGKVSEKSLPKNEKEDKENISENDREYSGDAQVDKKPENDIVKSPQENLREPKRKRGRPPSIAPTAVDSNSQTLQPITLELRRRKISKGCEVPLKRPRLDKNSSQEKSKNYSENTDKDLSRRRSSRLSTNGTHEILDPDLVVSDLVDTDPLQDTLSSTKESEEGQLKSALEAGQVSSALTCHSFGDGSGAAGLELNCPSMGENTMKTEPTSPLVELQEISTVEVTNTFKKTDDFGSSNAPAVDLDHKFRCKVVDCLKFFRKAKLLHYHMKYFHGMEKSLEPEESPGKRHVQTRGPSASDKPSQETLTRKRVSASSPTTKDKEKNKEKKFKEFVRVKPKKKKKKKKKTKPECPCSEEISDTSQEPSPPKAFAVTRCGSSHKPGVHMSPQLHGPESGHHKGKVKALEEDNLSESSSESFLWSDDEYGQDVDVTTNPDEELDGDDRYDFEVVRCICEVQEENDFMIQCEECQCWQHGVCMGLLEENVPEKYTCYVCQDPPGQRPGFKYWYDKEWLSRGHMHGLAFLEENYSHQNAKKIVATHQLLGDVQRVIEVLHGLQLKMSILQSREHPDLPLWCQPWKQHSGEGRSHFRNIPVTDTRSKEEAPSYRTLNGAVEKPRPLALPLPRSVEESYITSEHCYQKPRAYYPAVEQKLVVETRGSALDDAVNPLHENGDDSLSPRLGWPLDQDRSKGDSDPKPGSPKVKEYVSKKALPEEAPARKLLDRGGEGLLSSQHQWQFNLLTHVESLQDEVTHRMDSIEKELDVLESWLDYTGELEPPEPLARLPQLKHCIKQLLMDLGKVQQIALCCST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
103 | Phosphorylation | CWSDCRFYPAKVTAV HHCCCCEEEEEEEEE | 5.28 | - | |
112 | Ubiquitination | AKVTAVNKDGTYTVK EEEEEECCCCCEEEE | 51.43 | 29967540 | |
116 | Phosphorylation | AVNKDGTYTVKFYDG EECCCCCEEEEEECC | 18.31 | - | |
155 | Phosphorylation | PKETDHKSLSSSPDK CCCCCCCCCCCCCCH | 30.02 | 30266825 | |
157 | Phosphorylation | ETDHKSLSSSPDKRE CCCCCCCCCCCCHHH | 35.54 | 30266825 | |
158 | Phosphorylation | TDHKSLSSSPDKREK CCCCCCCCCCCHHHH | 51.70 | 30266825 | |
159 | Phosphorylation | DHKSLSSSPDKREKF CCCCCCCCCCHHHHH | 33.47 | 30266825 | |
177 | "N6,N6-dimethyllysine" | RKATVNVKKDKEDKP HHHHCCCCCCCCCCC | 50.48 | - | |
177 | Methylation | RKATVNVKKDKEDKP HHHHCCCCCCCCCCC | 50.48 | - | |
205 | Acetylation | GKLICSEKGKVSEKS CCEEECCCCCCCCCC | 47.97 | 25953088 | |
209 | Phosphorylation | CSEKGKVSEKSLPKN ECCCCCCCCCCCCCC | 42.67 | 22817900 | |
211 | Acetylation | EKGKVSEKSLPKNEK CCCCCCCCCCCCCCH | 50.19 | 25953088 | |
225 | Phosphorylation | KEDKENISENDREYS HHHHCCCCCCHHHHC | 41.76 | 28985074 | |
225 (in isoform 2) | Phosphorylation | - | 41.76 | - | |
231 | Phosphorylation | ISENDREYSGDAQVD CCCCHHHHCCCCCCC | 20.88 | - | |
232 | Phosphorylation | SENDREYSGDAQVDK CCCHHHHCCCCCCCC | 25.99 | - | |
240 | Sumoylation | GDAQVDKKPENDIVK CCCCCCCCCCCCCCC | 53.77 | - | |
240 | Sumoylation | GDAQVDKKPENDIVK CCCCCCCCCCCCCCC | 53.77 | - | |
248 | Phosphorylation | PENDIVKSPQENLRE CCCCCCCCHHHHCCC | 22.41 | 28985074 | |
254 (in isoform 2) | Phosphorylation | - | 70.52 | 24260401 | |
258 (in isoform 2) | Phosphorylation | - | 44.62 | 24260401 | |
263 (in isoform 2) | Phosphorylation | - | 29.79 | 24260401 | |
265 | Phosphorylation | RKRGRPPSIAPTAVD HHCCCCCCCCCCEEC | 33.78 | 27050516 | |
269 | Phosphorylation | RPPSIAPTAVDSNSQ CCCCCCCCEECCCCC | 30.23 | 28122231 | |
273 | Phosphorylation | IAPTAVDSNSQTLQP CCCCEECCCCCCCCE | 31.61 | 28122231 | |
275 | Phosphorylation | PTAVDSNSQTLQPIT CCEECCCCCCCCEEE | 28.61 | 28122231 | |
277 | Phosphorylation | AVDSNSQTLQPITLE EECCCCCCCCEEEHH | 27.47 | 26714015 | |
291 | Phosphorylation | ELRRRKISKGCEVPL HHHHHHHCCCCCCCC | 26.48 | 22334668 | |
299 | Acetylation | KGCEVPLKRPRLDKN CCCCCCCCCCCCCCC | 55.04 | 25953088 | |
321 | Acetylation | NYSENTDKDLSRRRS CCCCCCHHHHHHHHH | 59.54 | 25953088 | |
328 | Phosphorylation | KDLSRRRSSRLSTNG HHHHHHHHHCCCCCC | 20.28 | 28450419 | |
329 | Phosphorylation | DLSRRRSSRLSTNGT HHHHHHHHCCCCCCC | 35.11 | 28450419 | |
332 | Phosphorylation | RRRSSRLSTNGTHEI HHHHHCCCCCCCCCC | 20.79 | 28387310 | |
333 | Phosphorylation | RRSSRLSTNGTHEIL HHHHCCCCCCCCCCC | 42.11 | 28387310 | |
336 | Phosphorylation | SRLSTNGTHEILDPD HCCCCCCCCCCCCCC | 20.57 | 28387310 | |
347 | Phosphorylation | LDPDLVVSDLVDTDP CCCCCEEECCCCCCH | 20.11 | 28450419 | |
360 | Phosphorylation | DPLQDTLSSTKESEE CHHHHHHHCCCCCCC | 37.75 | 22210691 | |
361 | Phosphorylation | PLQDTLSSTKESEEG HHHHHHHCCCCCCCC | 46.76 | - | |
365 | Phosphorylation | TLSSTKESEEGQLKS HHHCCCCCCCCHHHH | 42.37 | - | |
408 | Phosphorylation | CPSMGENTMKTEPTS CCCCCCCCCCCCCCC | 18.75 | - | |
411 | Phosphorylation | MGENTMKTEPTSPLV CCCCCCCCCCCCCCE | 36.05 | 30278072 | |
414 | Phosphorylation | NTMKTEPTSPLVELQ CCCCCCCCCCCEEEE | 36.42 | 30278072 | |
415 | Phosphorylation | TMKTEPTSPLVELQE CCCCCCCCCCEEEEE | 27.27 | 30278072 | |
424 | Phosphorylation | LVELQEISTVEVTNT CEEEEECEEEEEECC | 26.16 | 22817900 | |
425 | Phosphorylation | VELQEISTVEVTNTF EEEEECEEEEEECCE | 26.75 | 28122231 | |
434 | Ubiquitination | EVTNTFKKTDDFGSS EEECCEEECCCCCCC | 53.66 | 29967540 | |
440 | Ubiquitination | KKTDDFGSSNAPAVD EECCCCCCCCCCCCC | 22.03 | 21963094 | |
451 | Ubiquitination | PAVDLDHKFRCKVVD CCCCCCHHHCCCHHH | 33.88 | 29967540 | |
467 | Acetylation | LKFFRKAKLLHYHMK HHHHHHHHHHHHHHH | 55.40 | 25953088 | |
488 | Phosphorylation | KSLEPEESPGKRHVQ CCCCCCCCCCCCCCC | 36.97 | 23401153 | |
491 | Acetylation | EPEESPGKRHVQTRG CCCCCCCCCCCCCCC | 42.59 | 25953088 | |
496 | Phosphorylation | PGKRHVQTRGPSASD CCCCCCCCCCCCCCC | 36.18 | 26552605 | |
500 | Phosphorylation | HVQTRGPSASDKPSQ CCCCCCCCCCCCCCH | 43.14 | 28555341 | |
502 | Phosphorylation | QTRGPSASDKPSQET CCCCCCCCCCCCHHH | 50.97 | 26552605 | |
504 | Acetylation | RGPSASDKPSQETLT CCCCCCCCCCHHHHH | 44.04 | 25953088 | |
504 | Ubiquitination | RGPSASDKPSQETLT CCCCCCCCCCHHHHH | 44.04 | 29967540 | |
506 | Phosphorylation | PSASDKPSQETLTRK CCCCCCCCHHHHHCC | 46.52 | 28555341 | |
509 | Phosphorylation | SDKPSQETLTRKRVS CCCCCHHHHHCCCCC | 26.28 | 26074081 | |
511 | Phosphorylation | KPSQETLTRKRVSAS CCCHHHHHCCCCCCC | 41.38 | 26074081 | |
516 | Phosphorylation | TLTRKRVSASSPTTK HHHCCCCCCCCCCCC | 26.85 | 28985074 | |
518 | Phosphorylation | TRKRVSASSPTTKDK HCCCCCCCCCCCCCH | 29.37 | 30266825 | |
519 | Phosphorylation | RKRVSASSPTTKDKE CCCCCCCCCCCCCHH | 26.44 | 30266825 | |
521 | Phosphorylation | RVSASSPTTKDKEKN CCCCCCCCCCCHHHH | 48.72 | 30266825 | |
522 | Phosphorylation | VSASSPTTKDKEKNK CCCCCCCCCCHHHHH | 40.40 | 30266825 | |
552 | Acetylation | KKKKKKTKPECPCSE CCCCCCCCCCCCCCH | 47.93 | 26051181 | |
558 | Phosphorylation | TKPECPCSEEISDTS CCCCCCCCHHCCCCC | 24.33 | 27732954 | |
562 | Phosphorylation | CPCSEEISDTSQEPS CCCCHHCCCCCCCCC | 37.81 | 27732954 | |
564 | Phosphorylation | CSEEISDTSQEPSPP CCHHCCCCCCCCCCC | 26.06 | 27732954 | |
565 | Phosphorylation | SEEISDTSQEPSPPK CHHCCCCCCCCCCCC | 37.22 | 27732954 | |
569 | Phosphorylation | SDTSQEPSPPKAFAV CCCCCCCCCCCEEEE | 53.75 | 27732954 | |
590 | Phosphorylation | HKPGVHMSPQLHGPE CCCCCCCCCCCCCCC | 8.46 | 30576142 | |
713 | Ubiquitination | GFKYWYDKEWLSRGH CCEEEECHHHHHHCC | 34.78 | - | |
727 | Ubiquitination | HMHGLAFLEENYSHQ CHHHHHHHHHHCCCH | 7.21 | 21963094 | |
737 | Acetylation | NYSHQNAKKIVATHQ HCCCHHHHHHHHHHH | 51.05 | 26051181 | |
788 | Ubiquitination | WKQHSGEGRSHFRNI CCCCCCCCCHHCCCC | 39.66 | 21963094 | |
802 | Phosphorylation | IPVTDTRSKEEAPSY CCCCCCCCHHHCCCC | 46.65 | - | |
803 | Acetylation | PVTDTRSKEEAPSYR CCCCCCCHHHCCCCC | 57.17 | 26051181 | |
803 | Sumoylation | PVTDTRSKEEAPSYR CCCCCCCHHHCCCCC | 57.17 | - | |
803 | Sumoylation | PVTDTRSKEEAPSYR CCCCCCCHHHCCCCC | 57.17 | - | |
818 | Acetylation | TLNGAVEKPRPLALP CCCCCCCCCCCCCCC | 39.46 | 23749302 | |
829 | Phosphorylation | LALPLPRSVEESYIT CCCCCCCCHHHHHCC | 31.76 | 24719451 | |
834 | Phosphorylation | PRSVEESYITSEHCY CCCHHHHHCCCHHHC | 16.11 | 24719451 | |
843 | Ubiquitination | TSEHCYQKPRAYYPA CCHHHCCCCHHCCCC | 15.25 | 21963094 | |
843 | Acetylation | TSEHCYQKPRAYYPA CCHHHCCCCHHCCCC | 15.25 | 19608861 | |
854 | Sumoylation | YYPAVEQKLVVETRG CCCCCCEEEEEEECC | 29.73 | - | |
854 | Sumoylation | YYPAVEQKLVVETRG CCCCCCEEEEEEECC | 29.73 | - | |
862 | Phosphorylation | LVVETRGSALDDAVN EEEEECCCHHHHHCC | 23.51 | 28634120 | |
878 | Phosphorylation | LHENGDDSLSPRLGW HHHCCCCCCCCCCCC | 35.17 | 30266825 | |
880 | Phosphorylation | ENGDDSLSPRLGWPL HCCCCCCCCCCCCCC | 16.36 | 30266825 | |
892 | Phosphorylation | WPLDQDRSKGDSDPK CCCCCCCCCCCCCCC | 49.64 | 25159151 | |
896 | Phosphorylation | QDRSKGDSDPKPGSP CCCCCCCCCCCCCCH | 65.56 | 30576142 | |
902 | Phosphorylation | DSDPKPGSPKVKEYV CCCCCCCCHHHHHHH | 30.03 | 25159151 | |
906 | Ubiquitination | KPGSPKVKEYVSKKA CCCCHHHHHHHCCCC | 49.83 | 29967540 | |
911 | Acetylation | KVKEYVSKKALPEEA HHHHHHCCCCCCCCC | 31.83 | 25953088 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHF20_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHF20_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
H31_HUMAN | HIST1H3A | physical | 22449972 | |
P53_HUMAN | TP53 | physical | 22864287 | |
DPOE3_HUMAN | POLE3 | physical | 26344197 | |
KANL3_HUMAN | KANSL3 | physical | 28514442 | |
KANL2_HUMAN | KANSL2 | physical | 28514442 | |
KAT8_HUMAN | KAT8 | physical | 28514442 | |
MCRS1_HUMAN | MCRS1 | physical | 28514442 | |
PTN14_HUMAN | PTPN14 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-843, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-878 AND SER-880, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-878 AND SER-880, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209, AND MASSSPECTROMETRY. |